Filing Details

Accession Number:
0001209191-17-046233
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-25 18:08:18
Reporting Period:
2017-07-25
Filing Date:
2017-07-25
Accepted Time:
2017-07-25 18:08:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1505512 Regulus Therapeutics Inc. RGLS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1465278 P Joseph Hagan C/o Regulus Therapeutics Inc.
10614 Science Center Drive
San Diego CA 92121
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-07-25 219,780 $0.91 241,297 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct